Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Total Debt: 2019-2025

Historic Total Debt for Burning Rock Biotech (BNR) over the last 1 years, with Jun 2025 value amounting to $2.0 million.

  • Burning Rock Biotech's Total Debt was N/A to $2.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $372,000 for FY2021, which is 93.00% down from last year.
  • According to the latest figures from Q2 2025, Burning Rock Biotech's Total Debt is $2.0 million, which was up 437.63% from $372,000 recorded in Q4 2021.
  • In the past 5 years, Burning Rock Biotech's Total Debt ranged from a high of $2.0 million in Q2 2025 and a low of $372,000 during Q4 2021.
  • Over the past 1 years, Burning Rock Biotech's median Total Debt value was $2.0 million (recorded in 2025), while the average stood at $2.0 million.
  • Data for Burning Rock Biotech's Total Debt shows a maximum YoY slumped of 93.00% (in 2021) over the last 5 years.
  • Burning Rock Biotech's Total Debt (Quarterly) stood at $372,000 in 2021, then followed by $2.0 million in 2025.
  • Its Total Debt stands at $2.0 million for Q2 2025, versus $372,000 for Q4 2021 and $5.3 million for Q4 2020.